Positive effects of short-term growth hormone treatment on lean body mass and BMC after a hip fracture
A double-blind placebo-controlled pilot study in 20 patients

References

• Alcner G, Cederholm T. Treatment of protein-energy mal-nutrition in chronic non-malignant disorders. Am J Clin Nutrition 2001; 74: 6–24.
   PubMedGoogle Scholar
• Andreassen T T, Jorgensen P H, Flyvbjerg A, Orskov H, Oxlund H. Growth hormone stimulates bone formation and strength of cortical bone in aged rats. J Bone Miner Res 1995; 10: 1057–67.
   PubMedGoogle Scholar
• Berglund-Roden M, Swierstra B A, Wingstrand H, Thorn-gren K G. Prospective comparison of hip fracture treat-ment: 856 cases followed for 4 months in the Netherlands and Sweden. Acta Orthop Scand 1994; 65: 287–94.
   Google Scholar
• Bravenboer N, Holzmann P, De Boer H, Roos J C, van Der Veen E A, Lips P. The effect of growth hormone (GH) on histomorphometric indices of bone structure and bone turnover in GH deficient men. J Clin Endocrinol Metab 1997; 82: 1818–22.
   Google Scholar
• Brixen K, Kassem M, Fink Eriksen E, Nielsen H, Flyvbjerg A, Mosekilde L. Growth hormone (GH) and adult bone remodeling: the potential use of GH in treatment of osteo-porosis. J Pediatr Endocinol 1993; 6: 65–71.
   PubMedGoogle Scholar
• Bäckman E, ()berg B. Isokinetic muscle torque in the dorsi-flexors of the ankle in children 6-15 years of age. Scand J Rehab Med 1989; 21: 97–103.
   Google Scholar
• Cummings S R, Black D M, Nevin M C, Browner W S, Cauley J A, Ensrud K, Genant H K, Palermo L, Scott J, Vogt T M. Bone density at various sites for prediction of hip fractures. Lancet 1993; 341: 72–5.
   PubMedGoogle Scholar
• Degerblad M, Bengtsson B A, Bramnert M, Johnell J, Manhem P, Rosen T, Thoren M. Reduced bone mineral density in adults with growth hormone (GH) deficiency: increased bone turnover during 12 months of GH substi-tution therapy. Eur J Endocrinol 1995; 133: 180–8.
   PubMedGoogle Scholar
• Fryburg D, Barret E. Growth hormone acutely stimulates skeletal muscle but not whole body protein synthesis in humans. Metabolism 1993; 42: 1223–7.
   PubMed Web of Science ®Google Scholar
• Gillberg P, Mallmin H, Petren-Mallmin M, Ljunghall S, Nilsson A G. Two years of treatment with recombinant human growth hormone increases bone mineral density in men with idiopathic osteoporosis. J Clin Endocrinol Metab 2002; 87: 4900–6.
   Google Scholar
• Hall K, Lundin G, Pávoa G. Serum levels of low molecular weight form of insulin-like growth factor binding protein in healthy subjects and patients with growth hormone deficiency, acromegaly and anorexia nervosa. Acta Endo-crinol 1988; 118: 321–6.
   Google Scholar
• Hedström M, Sääf M, Dalen N. Low IGF-I levels in hip frac-ture patients. A comparison of 20 coxarthrotic and 23 hip fracture patients. Acta Orthop Scand 1999; 70: 145–8.
   PubMed Web of Science ®Google Scholar
• Hilding A, Hall K, Wivall-Helleryd I-L, Saf M, Melin A-L, Thoren M. Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects. J Clin Endo-crinol Metab 1999; 84: 2013–9.
   Google Scholar
• Holloway L, Butterfield G, Hintz R, Gesundheit N, Marcus R. Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. Clin Endocrinol Metab 1994; 79: 470–9.
   Google Scholar
• Jiang Z M, He G Z, Zhang S Y, Wang X R, Yang N F, Zhu Y, Wilmore D W. Low-dose growth hormone and hypocalo-ric nutrition attenuate the protein-catabolic response after major operation. Ann Surg 1989; 10: 513–25.
   Google Scholar
• Johannsson G, Grimby G, Stibrant Sunnerhagen K, Bengts-son B A. Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH deficient adults. J Clin Endocrinol Metab 1997; 82: 2877–84.
   Google Scholar
• Johansson A, Eden-Engstrom B, Ljunghall S, Karlsson A, Burman P. Gender differences in the effects of long term growth hormone treatment on bone in adults with GH deficiency. J Clin Endocrinol Metab 1999; 84: 2002–7.
   PubMed Web of Science ®Google Scholar
• Jorgensen J, Thulesen L, Ingeman-Hansen T, Pedersen S, Joregensen J, Skakkebaek N, Christiansen J. Beneficial effects of growth hormone treatment in GH-deficient adults. The Lancet 1989; 3: 1221–5.
   Google Scholar
• Karantanas A, Kalef-Ezra J, Glaros D. Quantitative com-puted tomography for bone mineral measurement: techni-cal aspects, dosimetry, normal data and clinical applica-tions. Brit J Radiology 1991; 64: 298–304.
   PubMed Web of Science ®Google Scholar
• Karlsson M, Nilsson J A, Sernbo I, Redlund-Johnell I, Johnell 0, Obrant K. Changes of bone mineral mass and soft tissue composition after hip fracture. Bone 1996; 18: 19–22.
   Google Scholar
• Landin-Wilhelmsen K, Nilsson A, Bosaeus I, Bengtsson B A. Growth hormone increases bone mineral content in postmenopausal osteoporosis: A randomized pla-cebo-controlled study. J Bone Miner Res 2003; 18 (3): 393–405.
   Google Scholar
• Lange K, Isaksson F, Höjby Rasmussen M, Billow J, Juul A, Kjaer M. Gil administration and discontinuation in healthy elderly men; effects on body composition, Gil related serum markers, resting heart rate and oxygen uptake. Clin Endocrinol 2001; 55: 77–86.
   Google Scholar
• Lumbers M, Driver L T, Howland R J, Older MW, Williams C M. Nutritional status and clinical outcome in elderly female surgical orthopedic patients. Clin Nutr 1996; 15: 101–7.
   PubMed Web of Science ®Google Scholar
• Meunier P J, Boivin G. Bone mineral density reflects bone mass but also the degree of mineralization of bone: thera-peutic implications. Bone 1997; 21: 373–7.
   PubMed Web of Science ®Google Scholar
• Miinzer T, Harman M, Hees P, Shapiro E, Christmas C, Bel-lantoni M, Stevens T, O'Connor K, Pabst K, St Clair C, Sorkin J, Blackman M. Effects of Gil and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men. J Clin Endocrinol Metab 2001; 86: 3604–10.
   Google Scholar
• Murray R D, Skillicorn C J, Howell S J, Lissett CA, Rahim A, Shalet S M. Dose titration and patient selection increases the efficacy of Gil replacement in severely Gil deficient adults. Clin Endocrinol 1999; 50: 749–57.
   PubMedGoogle Scholar
• Neander G, Adolphson P, von Sivers K, Dahlborn M, Dalen N. Bone and muscle mass after femoral neck fracture. A controlled quantitative computed tomography study of osteosynthesis versus primary total hip arthroplasty. Arch Orhop Trauma Surg 1997; 116: 470–4.
   Google Scholar
• Papadakis M, Grady D, Black D, Tierney M, Gooding G, Schabelan M, Grunfeld C. Growth hormone replacement in healthy older improves body composition but not func-tional capacity. Ann Intern Med 1996, 124: 708–16.
   Google Scholar
• Petersen S, Holaday N, Jeevanandam M. Enhancement of protein synthesis efficiency in parentally fed trauma vic-tims by adjutant recombinant human growth hormone. J Trauma 1994; 36: 726–33.
   Google Scholar
• Rudman D, Feller A, Nagraj H, Gergans G, Lalitha P, Gold-berg A, Schlenker R, Cohn L, Rudman I, Mattson D. Effects of growth hormone in men over 60 years old. N Engl Med 1990; 323; 1–6.
   Google Scholar
• Slosman D 0, Casez J P, Pichard C, Rochat T, Fery F, Riz-zoli R et al. Assessment of whole-body composition with dual-energy x-ray absorptiometry. Radiology 1992; 185: 593–8.
   Google Scholar
• Symreng T. Arm anthropometry in a large reference popula-tion and in surgical patients. Clin Nutr 1982; 1: 211–9.
   PubMedGoogle Scholar
• Saf M, Hilding A, Thorén M, Troell S, Hall K. Growth hormone treatment of osteoporotic postmenopausal women—a one-year placebo-controlled study. Eur J Endocrinol 1999; 140: 390–9.
   Google Scholar
• Takla J, Ruokonen E, Webster N R, Nielasen M S, Zands-tra D F, Vundenlinckx G, Hinds C J. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341: 785–92.
   Google Scholar
• Thompson J, Butterfield G, Hintz L, van Loan M, Ghiron L, Hoffman A. The effects of recombinant human insu-lin-like growth factor I and growth hormone on body composition in elderly women. J Clin Endocrinol Metab 1995; 80: 1845–52.
   Google Scholar
• Van der Lely A, Lamberts S, Jauch K, Swiersta B, Hertlein H, De Vries D, Birkett M, Bates P, Blum W, Attanasio A. Use of human Gil in elderly patients with accidental hip fracture. Eur J Endocrinol 2000; 143: 585–92.
   PubMed Web of Science ®Google Scholar
• Vara-Thorbeck R, Guerrero J A, Rosell J, Ruiz-Requena E, Capitán J M. Exogenous growth hormone: Effects on the catabolic response to surgically produced acute stress and on postoperative immune function. World J Surg 1993; 17: 530–8.
   Google Scholar
• Vellas B, Conceiacao J, LaFont B, Garry P J, Adoue D, Albarede J L. Malnutrition and falls. Lancet 1990; 336: 1447.
   PubMed Web of Science ®Google Scholar
• Välimäki M, Salmela P, Salmi J, Viikari J, Kataja M, Turunen H, Soppi E. Effects of 42 months of Gil treat-ment on bone mineral density and bone turnover in Gil deficient adults. Eur J Endocrinol 1999; 140: 545–54.
   Google Scholar
• Weissberger A J, Anastasiadis A D, Sturgess I, Martin F C, Smith M A, Sonksen P H. Recombinant human growth hormone treatment in elderly patients undergoing elective total hip replacement. Clin Endocrinol 2003; 58: 99–107.
   PubMedGoogle Scholar
• Weissman C. The metabolic response to stress: an overview and update. Anestesiology 1990; 73: 308–27.
   PubMed Web of Science ®Google Scholar